M&A

Fibrosis-focused Tvardi to go public via merger with cash-strapped Cara
Fierce Biotech
Wed, 12/18/24 - 11:13 am
Cara Therapeutics
Tvardi Therapeutics
M&A
fibrosis
Pfizer expects $1B hit from IRA's Part D redesign and no major M&A in 2025
Fierce Pharma
Tue, 12/17/24 - 12:07 pm
Pfizer
Inflation Reduction Act
M&A
Regulatory conditions on Novo Holdings' $16.5 billion Catalent deal fulfilled, companies say
MSN/Reuters
Sun, 12/15/24 - 10:52 pm
Novo Holdings
M&A
Catalent
AbbVie to acquire Roche spinout Nimble in immune drug deal
BioPharma Dive
Fri, 12/13/24 - 11:49 am
AbbVie
Nimble Therapeutics
M&A
IL-23
Roche
After M&A rumors sparked stock volatility, Bausch + Lomb confirms it's exploring a sale
Fierce Pharma
Thu, 12/12/24 - 11:47 pm
Bausch + Lomb
M&A
Industry M&A volume declined 8% this year compared to '23
Fierce Biotech
Thu, 12/12/24 - 11:43 am
M&A
PwC
Patterson, a dental products distributor, agrees to $4.1B sale to healthcare investor
Medtech Dive
Thu, 12/12/24 - 11:38 am
Patterson Companies
dental
M&A
Medtech
Tenpoint, Visus merge in effort to push presbyopia-correcting eye drop over FDA finish line
Fierce Biotech
Thu, 12/12/24 - 11:38 am
Tenpoint Therapeutics
Visus Therapeutics
presbyopia
M&A
Reverse, reverse: Liver disease biotech Hepion and Pharma Two B call off merger
Fierce Biotech
Wed, 12/11/24 - 10:49 pm
M&A
Hepion Pharmaceuticals
Pharma Two B
liver disease
How the Omnicom-IPG merger could reshape pharma marketing
Medical Marketing and Media
Wed, 12/11/24 - 11:29 am
pharma marketing
Omnicom
IPG
M&A
How Trump’s second term will affect the medtech industry
Medtech Dive
Wed, 12/11/24 - 11:28 am
Medtech
Donald Trump
tarriffs
M&A
CDRH
LDTs
Roche said it didn’t want to buy Poseida last year: A look at how the $1.5B buyout came to be
Fierce Biotech
Tue, 12/10/24 - 10:00 pm
Roche
Poseida Therapeutics
M&A
cell therapy
With green light from European Commission, Novo Holdings' proposed $16.5B Catalent buyout nears close
Fierce Pharma
Sun, 12/8/24 - 09:37 pm
Novo Holdings
Catalent
Europe
M&A
CDMOs
Pharma hopes Trump will bring change to the FTC. They may be disappointed.
BioPharma Dive
Mon, 12/2/24 - 07:39 pm
pharma industry
FTC
Donald Trump
M&A
Top 8 Trends That Helped Define the Medical Device Industry in 2024
Medical Devices and Diagnostics Industry
Mon, 12/2/24 - 11:04 am
Medtech
digital health
CGMs
LDTs
sustainability
pulsed field ablation
artificial intelligence
M&A
robotic surgery
Roche to buy cell therapy developer Poseida for $1B
BioPharma Dive
Tue, 11/26/24 - 11:24 am
Roche
Poseida Therapeutics
M&A
cell therapy
cancer
Halozyme abandons its €2bn pursuit of Evotec
Pharmaphorum
Mon, 11/25/24 - 09:29 am
Halozyme Therapeutics
Evotec
M&A
Medtronic Acquires Fortimedix Surgical
Medical Devices and Diagnostics Industry
Thu, 11/21/24 - 10:46 pm
Medtech
Medtronic
Fortimedix
M&A
Novartis buys Kate Therapeutics, eyeing $55B CGT market opportunity by 2030
BioSpace
Thu, 11/21/24 - 11:54 am
Novartis
Kate Therapeutics
M&A
gene therapy
Henry Schein to acquire medical supplier Acentus
Medtech Dive
Thu, 11/21/24 - 11:44 am
Henry Schein
Acentus
M&A
Medtech
CGMs

Pages